Repaglinide
瑞格列奈
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameRepaglinide
Drug Alias Name +[15]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1997/12/22
Country/Territory +[13]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A
Develop Information
Active CompaniesSumitomo DainipponNovo Nordisk A/S
Inactive CompaniesMukoviszidose Institut GgmbhGemini Labs Llc
Active Indications
Inactive Indications